Tod's: UBS still on hold, TP unchanged
(CercleFinance.com) - UBS confirms its neutral ratig on the stock, along with its target price of E37 after the group announced its results.
The analyst believes that growth in EBIT and investments should continue.
EBIT of 41 million in H2 exceeded the expected 30 million euros expected (27 million euros according to UBS), with an EBIT margin of 7.5% (5.7% according to the consensus), analysts point out.
Tod's recorded net profit of 23 million euros, a long way off from the 5.9 million euro loss recorded a year earlier.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The analyst believes that growth in EBIT and investments should continue.
EBIT of 41 million in H2 exceeded the expected 30 million euros expected (27 million euros according to UBS), with an EBIT margin of 7.5% (5.7% according to the consensus), analysts point out.
Tod's recorded net profit of 23 million euros, a long way off from the 5.9 million euro loss recorded a year earlier.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.